For example, in a murine model of humanized breast cancer, the group of mice that received tumor cells with higher expression of CX3CL1 developed larger tumors, but the group that was also treated with Trastuzumab (an anti-HER-2 antibody) had a lower proportion of animals with metastases 20. This evidence concerns the gene CX3CL1 and breast carcinoma.